JPWO2022102737A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022102737A5 JPWO2022102737A5 JP2022562195A JP2022562195A JPWO2022102737A5 JP WO2022102737 A5 JPWO2022102737 A5 JP WO2022102737A5 JP 2022562195 A JP2022562195 A JP 2022562195A JP 2022562195 A JP2022562195 A JP 2022562195A JP WO2022102737 A5 JPWO2022102737 A5 JP WO2022102737A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- administration
- edaravone
- time interval
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025002313A JP2025061070A (ja) | 2020-11-12 | 2025-01-07 | エダラボン経口投与用医薬組成物およびその投与方法 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2020188514 | 2020-11-12 | ||
| PCT/JP2021/041673 WO2022102737A1 (ja) | 2020-11-12 | 2021-11-12 | エダラボン経口投与用医薬組成物およびその投与方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025002313A Division JP2025061070A (ja) | 2020-11-12 | 2025-01-07 | エダラボン経口投与用医薬組成物およびその投与方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022102737A1 JPWO2022102737A1 (cg-RX-API-DMAC7.html) | 2022-05-19 |
| JPWO2022102737A5 true JPWO2022102737A5 (cg-RX-API-DMAC7.html) | 2023-07-12 |
Family
ID=81602356
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562195A Pending JPWO2022102737A1 (cg-RX-API-DMAC7.html) | 2020-11-12 | 2021-11-12 | |
| JP2025002313A Pending JP2025061070A (ja) | 2020-11-12 | 2025-01-07 | エダラボン経口投与用医薬組成物およびその投与方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025002313A Pending JP2025061070A (ja) | 2020-11-12 | 2025-01-07 | エダラボン経口投与用医薬組成物およびその投与方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11911366B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4245303A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JPWO2022102737A1 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230098267A (cg-RX-API-DMAC7.html) |
| CN (1) | CN116761601A (cg-RX-API-DMAC7.html) |
| AR (1) | AR124062A1 (cg-RX-API-DMAC7.html) |
| AU (2) | AU2021380319B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3198014A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL302533A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202228678A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022102737A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024036261A2 (en) * | 2022-08-10 | 2024-02-15 | Kpr U.S., Llc | Occlusion detection system and method for a flow control apparatus |
| EP4559463A1 (en) * | 2023-11-23 | 2025-05-28 | Ferrer Internacional, S.A. | Edaravone or its salts for use in the treatment of oxidative stress-mediated neurodegenerative disorders |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61263917A (ja) | 1985-05-20 | 1986-11-21 | Mitsubishi Yuka Yakuhin Kk | 脳機能正常化剤 |
| JPH0531523A (ja) | 1991-07-26 | 1993-02-09 | Aichi Steel Works Ltd | ロ−ラ回転数・間隙測定可能な圧延機用ロ−ラガイド装置 |
| ES2248144T3 (es) | 2000-10-24 | 2006-03-16 | Mitsubishi Pharma Corporation | Medicamentos para tratar la esclerosis lateral amiotrofica (ela). |
| CN109125261B (zh) * | 2016-03-16 | 2021-11-30 | 苏州澳宗生物科技有限公司 | 依达拉奉剂型 |
| EP3785703A1 (en) * | 2017-01-17 | 2021-03-03 | Treeway TW001 B.V. | Treatment comprising oral or gastric administration of edaravone |
| CN110381923A (zh) * | 2017-01-17 | 2019-10-25 | 萃微Tw001公司 | 包括肠内施用依达拉奉的医学治疗 |
| BR112021008197A2 (pt) | 2018-11-02 | 2021-08-03 | Mitsubishi Tanabe Pharma Corporation | suspensão de edaravone para administração oral |
| JP7012792B2 (ja) | 2020-08-06 | 2022-01-28 | 株式会社 ディー・エヌ・エー | 動画を配信するためのシステム、方法、及びプログラム |
| US12194025B2 (en) | 2020-11-12 | 2025-01-14 | Mitsubishi Tanabe Pharma Corporation | Pharmaceutical composition for oral administration of edaravone and method of administering same |
-
2021
- 2021-11-12 JP JP2022562195A patent/JPWO2022102737A1/ja active Pending
- 2021-11-12 AR ARP210103147A patent/AR124062A1/es unknown
- 2021-11-12 AU AU2021380319A patent/AU2021380319B2/en active Active
- 2021-11-12 CN CN202180075839.XA patent/CN116761601A/zh active Pending
- 2021-11-12 EP EP21891982.7A patent/EP4245303A4/en active Pending
- 2021-11-12 CA CA3198014A patent/CA3198014A1/en active Pending
- 2021-11-12 TW TW110142253A patent/TW202228678A/zh unknown
- 2021-11-12 KR KR1020237017986A patent/KR20230098267A/ko not_active Ceased
- 2021-11-12 WO PCT/JP2021/041673 patent/WO2022102737A1/ja not_active Ceased
- 2021-11-12 IL IL302533A patent/IL302533A/en unknown
- 2021-12-29 US US17/564,538 patent/US11911366B2/en active Active
-
2023
- 2023-12-28 US US18/398,241 patent/US12478611B2/en active Active
-
2025
- 2025-01-07 JP JP2025002313A patent/JP2025061070A/ja active Pending
- 2025-05-22 AU AU2025203773A patent/AU2025203773A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023515472A5 (cg-RX-API-DMAC7.html) | ||
| JP2021504420A5 (cg-RX-API-DMAC7.html) | ||
| JP2010509326A5 (cg-RX-API-DMAC7.html) | ||
| JP2020527583A5 (cg-RX-API-DMAC7.html) | ||
| JP5232404B2 (ja) | 有胞子性乳酸菌含有抗感冒ウイルス又は抗インフルエンザウイルス用組成物 | |
| US5545668A (en) | Oral glutamine to reduce stomatitis | |
| TWI455723B (zh) | 納曲酮及安非他酮於治療超重或肥胖病患之用途 | |
| WO2004058243A1 (ja) | 肝癌発生・進展抑制剤 | |
| AU2012235869A1 (en) | Compositions for the treatment of neurologic disorders | |
| JP2010511039A5 (cg-RX-API-DMAC7.html) | ||
| JP2019218379A5 (cg-RX-API-DMAC7.html) | ||
| JPS59112948A (ja) | コレステロ−ルレベル低下剤 | |
| JP2002322088A (ja) | 口腔貼付用製剤 | |
| ES2763437T3 (es) | Composición para el tratamiento de la esterilidad | |
| US2438106A (en) | Peroral penicillin compositions | |
| JP2019531286A5 (cg-RX-API-DMAC7.html) | ||
| JP2024531799A5 (cg-RX-API-DMAC7.html) | ||
| JP2021512086A5 (cg-RX-API-DMAC7.html) | ||
| WO2006001492A1 (ja) | 栄養組成物および消化管機能低下予防・改善用組成物 | |
| CN103919774A (zh) | 去亚甲基小檗碱在制备降血脂药物中的应用 | |
| TW415843B (en) | Anti-cancer pharmaceutical compositions comprising a diaminotrifluoromethylpyridine derivatives or the pharmaceutically acceptable salts thereof | |
| US12514842B2 (en) | Use of a benzoate containing composition to treat neurodegenerative disorders | |
| JP5555401B2 (ja) | C型肝炎ウイルス陽性ヒト肝硬変患者用肝癌発生・進展抑制剤 | |
| CN109999044B (zh) | 一种含有醉茄素a的组合物及其应用 | |
| JP2023533472A5 (cg-RX-API-DMAC7.html) |